Delivery Order SPE2DB24D9144-SPE2DB25FCMLJ

Award Date 2/27/25
Potential Completion Date 3/20/25
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order worth $8,220.68 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price award for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product, with a period of performance through March 17, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,441.36 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,220.68 firm fixed-price delivery order is for the supply of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the...
The Defense Logistics Agency (DLA) awarded a $3,561.86 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The delivery order is for the pharmaceutical product Stelara 45 mg/0.5 ml syringe and is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $3,730.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of 4566523970 - STELARA 130 MG/26 ML VIAL 26ML, a specialized pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group Inc. under the DLA's SPE2DB program, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,312.30 firm fixed-price delivery order is for the provision of 4567422421 ! STELARA 130 MG/26 ML VIAL 26ML, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, which enables...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,730.56 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of Stelara 130mg/26ml pharmaceutical product, with a performance period through December 13, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of STELARA 90 MG/ML SYRINGEML, a specialized pharmaceutical product, at a ceiling value of $8,931.48. The contract has an ultimate completion date of October 25, 2024 and is a firm fixed-price delivery order. DMS Pharmaceutical Group Inc. holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $7,461.12 firm fixed-price delivery order is for the supply of STELARA 130 MG/26 ML VIAL 26ML, a pharmaceutical product. The award is part of a larger $4,999,999 indefinite delivery contract that DMS Pharmaceutical Group holds with DLA to provide a broad range of pharmaceutical items to military health...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,435.20, is for the delivery of the pharmaceutical product STELARA 130 MG/26 ML VIAL 26ML. This order is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at up to $499,999,999, which allows the DLA to...
  • SPE2DB24D9144
    Indefinite Delivery Contract
  • SPE2DB24D9144-SPE2DB25FCMLJ
    Delivery Order

This federal contract award is for the delivery of Stelara 90 mg/ml syringes to the Defense Logistics Agency (DLA). The $8,220.68 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. DMS Pharmaceutical Group has a $499,999,999 Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. This contract award is not associated with any set-aside designation. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides a diverse array of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to the Department of Defense.

Generated 6/1/25, 2:48 AM